Type 2 Diabetes

The SUMMIT VIP study shows conventional risk factors do not suffice in predicting heart complications.

Study shows mice with obesity and type 2 have significantly slower healing of wounds compared to those with undisturbed sleep.

Medications suggested for second- and third-line treatments for diabetes management following treatment failure with metformin and sulfonylureas.

Thorough knowledge of anti-diabetes medications found to lead to better management, adherence.

In part 2 of this Exclusive Interview, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about the educational benefit from using CGM for type 2 diabetes.

Investigators find patients treated with GLP-1 drug had significantly lower number of amputations compared to placebo group.

Recent study shows improvements in insulin resistance and endotoxin-induced inflammation after taking probiotic supplementation, compared to placebo.

Recent studies show continued benefit in decreasing all-cause mortality from cardiovascular disease.

People with type 2 diabetes found at increased risk for microvascular and macrovascular complications.

Can neuromodulation prevent the onset of metabolic dysfunction associated with the onset of diabetes?